Lazard Asset Management
TSVT

Lazard Asset Management’s 2seventy bio TSVT Stock Holding History

Lazard Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-998
Closed -$4K – 2536
2025
Q1 		$4K Sell
998
-830
-45% -$2.64K ﹤0.01% 2188
2024
Q4 		$5K Buy
1,828
+1,721
+1,608% +$7.06K ﹤0.01% 2133
2024
Q3 		$0 Sell
107
-290
-73% -$1.31K ﹤0.01% 2460
2024
Q2 		$1K Sell
397
-7,102
-95% -$32K ﹤0.01% 2191
2024
Q1 		$39K Sell
7,499
-3,718
-33% -$17.5K ﹤0.01% 1768
2023
Q4 		$47K Buy
11,217
+5,915
+112% +$18.2K ﹤0.01% 1905
2023
Q3 		$20K Buy
5,302
+226
+4% +$1.48K ﹤0.01% 2100
2023
Q2 		$50K Buy
5,076
+35
+0.7% +$371 ﹤0.01% 1837
2023
Q1 		$50K Sell
5,041
-6,726
-57% -$76.9K ﹤0.01% 1800
2022
Q4 		$110K Buy
11,767
+3,063
+35% +$43.2K ﹤0.01% 1494
2022
Q3 		$126K Buy
8,704
+7,495
+620% +$111K ﹤0.01% 1384
2022
Q2 		$15K Buy
1,209
+53
+5% +$722 ﹤0.01% 2172
2022
Q1 		$19K Buy
1,156
+319
+38% +$5.41K ﹤0.01% 2079
2021
Q4 		$20K Buy
+837
New +$26.1K ﹤0.01% 2049

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lazard Asset Management's TSVT Position: Q2 2025 in Review

Lazard Asset Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 998 shares — an estimated $4K sold.

Lazard Asset Management first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $126K in Q3 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Lazard Asset Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 998 2seventy bio shares in Q2 2025, an estimated $4K.
  • Lazard Asset Management first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Lazard Asset Management's 2seventy bio position peaked at $126K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.